June 8-10, 2014 - Nice, France


Get Adobe Flash player
Industry sponsored symposia Auditorium
09.45 - 10.30   MONDAY JUNE 9
    HTN Technology matters
    Chairman: Max Amor
    Return on experience
Renal denervation: technology and perspectives, Jean-Pascal Peyre
The Vessix Technology, Piero Montorsi
14.15 - 15.50   MONDAY JUNE 9
    Meet the companies: Hot topics &
the newest interventional techniques
    Moderators: C. Mialhe, R. McWilliams, F. Setacci
    14.15 - Sustained durability of the new generation stent graft: the Endurant case example. Presenting the results of the ENGAGE registry at 3 years, A. Sauguet
    14.25 - Treating EVAR challenging anatomy with anatomical fixation, J-P. de Vries
    14.35 - A novel carotid artery stent for sustained embolic protection, M. Amor
    14.55 - New devices (S.M.A.R.T® Flex and SABER™ .018) for PAD treatment and BTK,
E. Ducasse
    15.15 - BATTLE: the rationale for comparing BMS and DES, Y. Gouëffic
    15.25 - New perspectives in Atherectomy and Thrombectomy, TBC
    15.35 - New Use of 4 Fr SES for peripheral treatment: options and advantages, E. Ducasse
    15.45 - Treatment of arterial and venous occlusions with Rotarex and Aspirex mechanical debulking, M. Amor
16.30 - 17.15   MONDAY JUNE 9
    Current endovascular treatment of the SFA
    Chairman: Max Amor
    Speakers: Massimiliano Di Primio, Jonathan Sobocinski
    Review of recent clinical data
Unique character of the SFA and the different stent designs
Review of the current treatment options
Abbott Vascular current and future solutions
10.00 - 10.45   TUESDAY JUNE 10
    Prime time for drug eluting balloons?
Hard facts and recent outcomes
    ChairmenMax Amor, Yann Gouëffic
Introduction and objectives
Latest Evidence about In.Pact DEB usage in fempop segment, Gunnar Tepe
Role of stenting in DEB era, Marianne Broadman
Panel discussion & take home messages